Gilead Sciences Inc. (GILD) News Headlines

▮ More

Date

Headline

2/19/2020 8:35:12 AM Gilead Sciences Names Michael Quigley SVP, Research Biology

2/10/2020 8:53:12 AM FDA Grants Priority Review For Kite's KTE-X19 BLA - Quick Facts

2/10/2020 8:35:58 AM FDA Grants Priority Review For Kite's KTE-X19 BLA In Relapsed Or Refractory Mantle Cell Lymphoma

2/4/2020 5:48:18 PM Gilead Sciences Q4 Profit Misses Estimates

2/4/2020 4:08:14 PM Gilead Sciences Inc. Q4 adjusted earnings Miss Estimates

2/4/2020 4:05:56 PM Gilead Sciences Inc. (GILD) Declares Quarterly Dividend of $ 0.68, Record Date 3/13/2020

2/4/2020 4:05:14 PM Gilead Sciences Declares Q1 Dividend Of $0.68/share, Payable March 30/ Record March 13

2/4/2020 4:03:25 PM Gilead Sciences Q4 EPS $2.12; Non-GAAP EPS $1.30

2/4/2020 3:00:15 PM Gilead Sciences Q4 19 Earnings Conference Call At 4:30 PM ET

2/4/2020 7:18:40 AM Momentum Stocks To Watch: Gilead Sciences Inc. (GILD)

2/4/2020 6:05:02 AM Gilead Sciences Q4 19 Earnings Conference Call At 4:30 PM ET

1/30/2020 4:07:38 PM Gilead Sciences Adds Sandra Horning To Board

1/13/2020 11:30:09 AM Gilead Sciences To Present At J.P. Morgan Conference; Webcast At 12:30 PM ET

1/13/2020 6:08:00 AM Gilead Invests In Kyverna Therapeutics, Enters License Agreement - Quick Facts

1/13/2020 5:51:03 AM Kyverna Therapeutics Enters Into Strategic Collaboration With Gilead Sciences; Names Dominic Borie CEO

1/9/2020 8:24:12 PM Gilead Science Holds 25.84% Of Galapagos Shares

1/9/2020 8:56:05 AM Gilead Sciences Licenses Portfolio Of HIV Antibodies From Rockefeller

1/9/2020 8:33:41 AM Gilead Sciences Licenses The Rockefeller University's Portfolio Of Broadly Neutralizing Antibodies Against HIV

12/24/2019 1:19:38 AM Gilead's Japan Unit In Deal With Eisai To Co-Promote RA Drug Filgotinib

12/24/2019 1:05:17 AM Gilead Sciences K.K. And Eisai Enter Agreement For Distribution, Co-promotion Of Filgotinib In Japan